Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Role of Mitochondria in Variable Penetrance of Schizophrenia in 22q11.2 Deletion Syndrome via Influence on Presynaptic Mechanisms of Glutamate Release

Award Number: K08MH138821
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 07/15/2026
PERIOD OF PERFORMANCE END DATE: 07/14/2030

Group Awards By:

View Award Description

Role of Mitochondria in Variable Penetrance of Schizophrenia in 22q11.2 Deletion Syndrome via Influence on Presynaptic Mechanisms of Glutamate Release - PROJECT SUMMARY/ABSTRACT Schizophrenia (SZ) remains one of the most debilitating psychiatric disorders and mechanistic understanding of the disease is minimal. Glutamatergic neurotransmission may play a role in SZ, but this has been difficult to study directly as the developing brain is inaccessible and complicated psychiatric syndromes cannot be easily replicated in non-human animals. Work using neurons derived from patient stem cells (iNeurons) has demonstrated a way to circumvent these limitations, and data from Dr. Anderson’s lab suggest the variable penetrance SZ in a well-defined neurodevelopmental disorder (22q11.2 deletion syndrome; 22qDS) corresponds to impaired oxidative phosphorylation (OXPHOS) in mitochondria. This proposal addresses the fundamental question of how alterations in mitochondrial function lead to complex psychiatric symptoms of SZ. AIM1 will test the hypothesis that mitochondrial dysfunction in presynaptic compartments results in diminished glutamate release in iNeurons from 22qDS individuals with SZ (22q+SZ) relative to those without SZ [22q(-)SZ]. Optical imaging of glutamate (AIM1.1) and synaptic vesicle cycling (AIM1.2) will be used to assess glutamate release from individual nerve terminals by independent methods under both high and low frequency neuronal stimulation. AIM2 will use computational modeling to access how alterations in presynaptic mitochondrial function contribute to circuit connectivity and entropy (disorder) in (22q+SZ) and [22q(-)SZ] iNeurons. This proposal fits within NIMH’s Strategic Plan to define brain mechanisms underlying behavior and mental illness and is expected to generate insights into mitochondrial influence on presynaptic function and glutamatergic neurotransmission in the emergence of SZ symptoms in 22qDS while also establishing a robust model of human cellular, synaptic, and circuit neuropathology in patient derived cells. Dr. Rossano will receive training in induced pluripotent stem cell models, medium-to-high throughput synaptic imaging in patient-derived cells, computational modeling of circuit connectivity, and integration of mitochondrial biology with synaptic physiology. Drs. Anderson and Goldberg possess complementary expertise and are uniquely suited for this proposal. A thoughtfully selected advisory committee will provide further scientific and career mentorship. Together with the world-class resources available at the Children’s Hospital of Philadelphia and the University of Pennsylvania the proposed scientific and training objectives will allow Dr. Rossano to establish an independent research program focused on synaptic neuroscience and mitochondrial biology as therapeutically targetable mechanisms underlying symptoms in SZ, autism, and additional neurodevelopmental disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $721,440 )
2026	2026	THE CHILDREN'S HOSPITAL OF PHILADELPHIA	3401 CIVIC CENTER BLVD	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Mental Health Research Grants	000	1	7/15/2026	NEW	$721,440
														Subtotal = $721,440

Grand Total All Awards = $721,440

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of Mitochondria in Variable Penetrance of Schizophrenia in 22q11.2 Deletion Syndrome via Influence on Presynaptic Mechanisms of Glutamate Release

Award Number: K08MH138821

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 07/15/2026

PERIOD OF PERFORMANCE END DATE: 07/14/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer